202 related articles for article (PubMed ID: 28008988)
1. Prognostic value of inflammation-based scores in patients with osteosarcoma.
Liu B; Huang Y; Sun Y; Zhang J; Yao Y; Shen Z; Xiang D; He A
Sci Rep; 2016 Dec; 6():39862. PubMed ID: 28008988
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma.
Li YJ; Yang X; Zhang WB; Yi C; Wang F; Li P
Cancer Manag Res; 2017; 9():443-451. PubMed ID: 29033609
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients.
Yang S; Wu C; Wang L; Shan D; Chen B
Int J Clin Exp Pathol; 2020; 13(3):515-524. PubMed ID: 32269690
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma.
Li YJ; Yao K; Lu MX; Zhang WB; Xiao C; Tu CQ
Onco Targets Ther; 2017; 10():5255-5261. PubMed ID: 29138578
[TBL] [Abstract][Full Text] [Related]
7. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis.
Song X; Zhang H; Yin F; Guo P; Yang X; Liu J; Han Y; Ren Z
Mediators Inflamm; 2021; 2021():3456629. PubMed ID: 34720749
[TBL] [Abstract][Full Text] [Related]
8. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
9. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.
Yamagishi T; Fujimoto N; Nishi H; Miyamoto Y; Hara N; Asano M; Fuchimoto Y; Wada S; Kitamura K; Ozaki S; Kishimoto T
Lung Cancer; 2015 Oct; 90(1):111-7. PubMed ID: 26259877
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma.
Liu T; Fang XC; Ding Z; Sun ZG; Sun LM; Wang YL
FEBS Open Bio; 2015; 5():682-7. PubMed ID: 26380812
[TBL] [Abstract][Full Text] [Related]
12. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
13. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
14. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma.
Xia WK; Liu ZL; Shen D; Lin QF; Su J; Mao WD
World J Surg Oncol; 2016 Apr; 14():127. PubMed ID: 27125872
[TBL] [Abstract][Full Text] [Related]
15. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.
Chen C; Sun P; Dai QS; Weng HW; Li HP; Ye S
PLoS One; 2014; 9(11):e112581. PubMed ID: 25393117
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Yao C; Liu X; Tang Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic values of selected inflammation based scores in patients with medullary thyroid carcinoma: A pilot study.
Jiang K; Lei J; Li C; Shu K; Li W; Zhang Y; Li Z; Gong R; Zhu J
J Surg Oncol; 2017 Sep; 116(3):281-287. PubMed ID: 28556902
[TBL] [Abstract][Full Text] [Related]
18. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
19. Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors.
Yang L; Fu M; Yu L; Wang H; Chen X; Sun H
Front Endocrinol (Lausanne); 2024; 15():1293842. PubMed ID: 38370351
[TBL] [Abstract][Full Text] [Related]
20. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
Xu XL; Yu HQ; Hu W; Song Q; Mao WM
PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
